Sort
21,453 grants matching “tuberculosis”
METHODS FOR EVALUATING VACCINE EFFICACY
$347,928Emory University · R01 · FY2000 · AI
Development of Aersolized Vaccines
$347,861Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Altered immune-endocrine axis in type 2 diabetes and tuberculosis risk
$347,839Katharina Ronacher · Stellenbosch University · R01 · FY2017 · AI
Principles of Protein Mimicry of DNA
$347,830Michael D Brenowitz · Albert Einstein College Of Medicine · R01 · FY2009 · GM
Flavin-Containing Monooxygenase in Lung
$347,804David E. Williams · Oregon State University · R01 · FY2012 · HL
Developing High-Throughput Assays for M. tuberculosis Tat Pathway Inhibitors
$347,800Miriam S. Braunstein · Univ Of North Carolina Chapel Hill · R01 · FY2013 · AI
Target and Non-target Based Resistance to Bedaquiline in South Africa
$347,754Ndivhu Makhado · Sefako Makgatho Health Sciences University · R01 · FY2023 · AI
Non-invasive diagnosis of adult pulmonary tuberculosis
$347,751Gerard A Cangelosi · University Of Washington · R01 · FY2022 · AI
Structure and Function of RNA Polymerase in E.coli
$347,490Arkady Mustaev · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2010 · GM
Biogenesis of lipoarabinomannan in mycobacteria
$347,423Colorado State University-Fort Collins · R01 · FY2005 · AI
Optimal dosing of 1st line antituberculosis and antiretroviral drugs in children
$347,419Helen McIlleron · University Of Cape Town · R01 · FY2013 · HD
Antibody Protection in Histoplamosis
$347,418Joshua D Nosanchuk · Albert Einstein College Of Medicine · R01 · FY2009 · AI
Antibody Protection in Histoplamosis
$347,418Joshua D Nosanchuk · Albert Einstein College Of Medicine · R01 · FY2008 · AI
Structures of RNA Processing and Silencing Enzymes in Prokaryotes
$347,252Hong Li · Florida State University · R01 · FY2019 · GM
Structures of RNA Processing and Silencing Enzymes in Prokaryotes
$347,252Hong Li · Florida State University · R01 · FY2018 · GM
Mouse and ENU Core
$347,204Gregory M Barton · University Of California Berkeley · P01 · FY2012 · AI
Discovering a Combination Therapeutic Approach to Use in the Treatment of Cryptoc
$347,172Mitchell W Mutz · Amplyx Pharmaceuticals, Inc. · R43 · FY2014 · NS
Childhood Omics and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings
$347,159Adithya Cattamanchi · University Of California-Irvine · R01 · FY2024 · AI
Inhibition of the Nonmevalonate pathway to Kill Mycobacterium tuberculosis
$347,142Cynthia Schieck Dowd · George Washington University · RC1 · FY2010 · AI
Macaque T cell signatures of Mtb control
$347,100Jyothi Rengarajan · Emory University · U19 · FY2017 · AI
A Computer Modeling Approach to Create an Antifungal to Improve the Treatment of
$347,057Mitchell W Mutz · Amplyx Pharmaceuticals, Inc. · R43 · FY2013 · NS
BU Clinical HIV/AIDS Research Training Program
$347,049C Robert Horsburgh · Boston Medical Center · T32 · FY2017 · AI
NOVEL DRUG DESIGN AND HIGH THROUGHPUT SCREENING
$347,019Edith Porter · California State University Los Angeles · P20 · FY2008 · MD
Pharmacometric optimization of second line drugs for MDR tuberculosis treatment
$346,986Helen McIlleron · University Of Cape Town · R01 · FY2019 · AI
PROTECTION FROM AMINOGLYCOSIDE OTOTOXICITY
$346,970University Of Michigan At Ann Arbor · R01 · FY2004 · DC